3-Indoleacetic Acid-Modified Chondroitin Sulfate-Mediated Paclitaxel Nanocrystal Assembly for the Treatment of Pancreatic Cancer
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c19450 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2025. Written by Yueting Zhu and 7 co-authors. Institution: Key Laboratory of Drug- Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-S…. Major MEDLINE topics: Pancreatic Neoplasms, Chondroitin Sulfates, Paclitaxel, Nanoparticles. Cited 7 times so far (Crossref); 40 references. Funded by: Science and Technology Department of Sichuan Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory of Drug- Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial…
- Department of Oncology, Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
- School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
ORCID profiles: Tao Gong, Zhirong Zhang, Yao Fu
Funding
- Science and Technology Department of Sichuan Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Higher Education Discipline Innovation Project
- MOE Key Laboratory of Drug Targeting and Drug Delivery System
Cite
APA
Zhu, Y., Hu, A., Chen, M., Zhang, Y., Gong, T., Zhang, Z., Yu, R., & Fu, Y. (2025). 3-Indoleacetic Acid-Modified Chondroitin Sulfate-Mediated Paclitaxel Nanocrystal Assembly for the Treatment of Pancreatic Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c19450
Vancouver
Zhu Y, Hu A, Chen M, Zhang Y, Gong T, Zhang Z, et al. 3-Indoleacetic Acid-Modified Chondroitin Sulfate-Mediated Paclitaxel Nanocrystal Assembly for the Treatment of Pancreatic Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c19450
BibTeX
@article{Zhu2025,
author = {Zhu, Yueting and Hu, Aolei and Chen, Meilin and Zhang, Yunting and Gong, Tao and Zhang, Zhirong and Yu, Ruilian and Fu, Yao},
title = {3-Indoleacetic Acid-Modified Chondroitin Sulfate-Mediated Paclitaxel Nanocrystal Assembly for the Treatment of Pancreatic Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c19450}
}
EUVIMED